NRNP6566 Week 7 Knowledge Check

NRNP6566 Week 7 Knowledge Check pH pCO2 pO2 HCO3 7.36 30 80 15 Compensated metabolic acidosis with no hypoxemia (metabolic acidosis with respiratory alkalosis) Ph – normal (leaning on acidosis ) pCO2 – decreased (respiratory alkalosis) HCO3 – decreased (rmetabolic acidosis) Metabolic acidosis (decreased HCO3) with no hypoxemia (pO2 is 80, normal) Fully compensated due to normal pH. Respiratory (pCO2) is leading to alkalemia to compensate for the metabolic acidosis. QUESTION 2 1. A 54 year old female has a 30 year pack smoking history. She recently underwent pulmonary function testing which showed moderate obstructive lung disease. What would your treatment plan (including medications) include for this patient? The main risk factor for COPD is smoking. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) explained that smoking cessation is the key (GOLD, 2020). Pharmacotherapy and nicotine replacement have increased the abstinence rates long term. Nicotine replacement products can be suggested to this patient, like gums, inhalers, nasal sprays, patches, sublingual, or tablets. The use of these methods increases success rates in smoking cessation. Pharmacotherapy decreases COPD symptoms, reduces exacerbations both in frequency and severity, and improves the patient’s health status and exercise tolerance. The patient can be prescribed varenicline, bupropion, and nortriptyline which are medications with proven long- term quit rates. However, behavioral modification should be a part of the treatment plan through professional counseling and positive emotional support. Inhaled bronchodilators are the baseline in symptom management in COPD. The patient can be prescribed short-acting beta antagonists that can be used